News Releases

25 Aug '21
GAIN Trial analysis of anti-P. gingivalis antibodies in cerebrospinal fluid supports upstream role of pathogenic bacterium in key Alzheimer’s pathologies SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 25, 2021-- Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer’s
Displaying 1 - 10 of 27